Recruiting NA Laparoscopic Cholecystectomy

Compares treatment options for Laparoscopic Cholecystectomy

Official title Ultrasound Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

ClinicalTrials.gov ID: NCT06588777

What this study is testing

What it's testing
This study aims to compare the efficacy of using Ultrasound guided modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) versus quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy under general anesthesia.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 71

You may be able to join if

  • Adult patients aging ≥ 21 years to ≤ 70 of both sexes.
  • Patients undergoing Laparoscopic cholecystectomy surgeries.
  • ASA physical status classes I - II.

You likely can't join if

  • Patient's refusal of procedure or participation in the study.
  • ASA classes III or above.
  • Coagulopathy and bleeding disorders.
  • Evidence of Local skin infections at site of injection.
  • Body mass index \>40kg/m2
  • A history of relevant local anesthetic allergy.

The study team makes the final eligibility decision.

Where it's taking place

  • Cairo, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 71 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.